Latest Breaking News On - Primon lara jr - Page 1 : comparemela.com
E-Mail
IMAGE: Sumanta Pal, MD, a SWOG Cancer Research Network researcher and City of Hope physician, led a study that sets a new standard of care for metastatic papillary kidney cancer view more
Credit: City of Hope
In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical practice.
These findings will be presented at ASCO s virtual 2021 Genitourinary Cancers Symposium on Feb. 13, 2021 at 1 p.m. ET. The findings will be simultaneously published in
ArizonaUnited-statesCaliforniaOklahomaWayne-state-universityMichiganJohn-wrightScott-coleLos-angelesCatherine-tangenIanm-thompson-jrNaomi-balzer-haas